Characteristics | HFpEF | p value | |
---|---|---|---|
No | Yes | ||
Age (years) | 68.3 ± 12.3 | 75.8 ± 8.6 | <0.001 |
Female, n (%) | 287 (40.9) | 57 (53.8) | 0.013 |
Hypertension, n (%) | 362 (51.6) | 55 (51.9) | 0.962 |
Smoking, n (%) | 163 (23.3) | 26 (24.5) | 0.773 |
Duration of diabetes (year) | 9.9 ± 8.0 | 12.4 ± 9.7 | 0.013 |
SBP (mmHg) | 136.8 ± 19.6 | 138.1 ± 19.3 | 0.512 |
DBP (mmHg) | 79.5 ± 11.1 | 77.6 ± 10.2 | 0.103 |
BMI (kg/m2) | 24.3 ± 3.9 | 24.3 ± 3.1 | 0.946 |
Obesity, n (%) | 102 (14.6) | 14 (13.2) | 0.713 |
Laboratory | |||
 FPG (mmol/L) | 7.77 ± 3.04 | 7.95 ± 3.80 | 0.589 |
 Lg HOMA-IR | 0.56 ± 0.33 | 0.67 ± 0.32 | 0.001 |
 HbA1c (%) | 8.16 ± 1.96 | 7.86 ± 1.77 | 0.134 |
 Albumin (g/L) | 38.91 ± 4.98 | 36.88 ± 4.85 | <0.001 |
 Uric acid (μmol/L) | 331.77 ± 98.71 | 371.18 ± 113.06 | 0.001 |
 Creatinine (μmol/L) | 80.51 ± 23.69 | 94.04 ± 27.40 | <0.001 |
 lg Alb/Cr (mg/g) | 1.68 ± 0.70 | 1.89 ± 0.67 | 0.004 |
 Micro-albuminuria, n (%) | 389 (55.5) | 71 (67.0) | 0.026 |
 NT-proBNP (pg/mL) | 189.86 ± 70.09 | 645.00 ± 264.26 | <0.001 |
 TG (mmol/L) | 1.81 ± 1.11 | 2.03 ± 1.66 | 0.184 |
 TC (mmol/L) | 4.81 ± 1.15 | 4.74 ± 1.20 | 0.518 |
 HDL-C (mmol/L) | 1.11 ± 0.34 | 1.13 ± 0.53 | 0.728 |
 LDL-C (mmol/L) | 2.73 ± 0.84 | 2.66 ± 0.86 | 0.476 |
 Dyslipidemia, n (%) | 370 (52.8) | 64 (60.4) | 0.144 |
 Albumin-adjusted calcium (mg/dL) | 8.96 ± 0.36 | 9.22 ± 0.44 | <0.001 |
 Phosphate (mg/dL) | 3.55 ± 0.45 | 3.57 ± 0.48 | 0.698 |
 Calcium–phosphate product (mg2/dL2) | 31.79 ± 4.44 | 32.44 ± 4.79 | 0.167 |
Echocardiographic characteristics | Â | ||
 LAD (mm) | 37.65 ± 4.65 | 41.67 ± 5.77 | <0.001 |
 AOD (mm) | 32.49 ± 3.33 | 32.46 ± 3.04 | 0.927 |
 LVIDD (mm) | 47.21 ± 4.23 | 48.10 ± 4.90 | 0.048 |
 LVIDS (mm) | 29.95 ± 3.49 | 31.35 ± 4.04 | 0.001 |
 IVSD (mm) | 10.60 ± 1.52 | 11.57 ± 1.90 | <0.001 |
 PWTD (mm) | 9.76 ± 1.27 | 10.46 ± 1.59 | <0.001 |
 RWT | 0.42 ± 0.07 | 0.44 ± 0.09 | 0.01 |
 LVMI (g/m2) | 99.30 ± 21.10 | 118.35 ± 30.79 | <0.001 |
 LVEF (%) | 65.95 ± 5.35 | 66.86 ± 7.23 | 0.217 |
 E/A | 1.10 ± 0.21 | 0.91 ± 0.20 | <0.001 |
 DT (ms) | 208.51 ± 54.79 | 265.70 ± 50.65 | <0.001 |
LV geometry | |||
 Normal, n (%) | 309 (44.1) | 22 (20.8) | <0.001 |
 Concentric remodeling, n (%) | 163 (23.3) | 14 (13.2) | |
 Eccentric hypertrophy, n (%) | 110 (15.7) | 22 (20.8) | |
 Concentric hypertrophy, n (%) | 119 (17.0) | 48 (45.3) | |
  LVH, n (%) | 229 (32.7) | 70 (66.0) | <0.001 |